In the manufacturing of cell-based therapeutics, isolating cells via DNA aptamers is an attractive alternative to magnetic-activated cell sorting.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$79.00 per year
only $6.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
FDA approval brings first gene therapy to the United States. United States Food and Drug Administration Press Release (August 30, 2017).
Kalos, M. et al. Sci. Transl. Med. 3, 95ra73 (2011).
Kochenderfer, J. N. et al. Blood 119, 2709–2720 (2012).
Brentjens, R. J. et al. Sci. Transl. Med. 5, 177ra138 (2013).
Wang, X. et al. Blood 127, 2980–2990 (2016).
Brown, C. E. N. Engl. J. Med. 375, 2561–2569 (2016).
Turtle, C. J. J. Clin. Invest. 126, 2123–2138 (2016).
Kacherovsky, N. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-019-0411-6 (2019).
Rights and permissions
About this article
Cite this article
Chen, Y.Y. Cell fishing with DNA aptamers. Nat Biomed Eng 3, 757–758 (2019). https://doi.org/10.1038/s41551-019-0438-8